7
• This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

Embed Size (px)

Citation preview

Page 1: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• This parameter is most useful for documentation of severity of asthma

(a) PEFR (b) FEV1 (c) FVC (d) FEV25

Page 2: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• This abnormaility of PEFR is NOT suggestive of asthma

• (a) diurnal variation of >20% (b) < 80% of predicted © improvement of > 20% after bronchodilator therapy (d) iurnal vaiation of <30%

Page 3: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• A child with recurrent wheezing, clubbing and malabsorption is likey to be a case of

• (a) severe bronchial asthma (b) bronchiectesis © cystic fibrosis (d) foreign body inhalation

Page 4: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• Alternative second-line therapy in combination with inhaled glucocorticoids in moderate to severe asthma in children is

• (a) salbutamol (b) theophylline © cromolyn (d) salmetrol

Page 5: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• MDIs should be used for (a) all ages (b) infants © school going children (d) teenages

Page 6: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• An asthmatic child on medication has 3 day symptoms per week and used salbutamol for it, awakes up at night coughing but has had only 2 exacerbations in the last 1 year. He is most likely

• (a) controlled (b)mildly symptomatic © uncontrolled (d) partially controlled

Page 7: This parameter is most useful for documentation of severity of asthma (a)PEFR (b)FEV1 (c)FVC (d)FEV25

• In home treatment of acute exacerbation of asthma short acting beta 2 agonist by MDI and spacer is given, one puff very 30-60 seconds for a maximum of __ doses

(a) 2 (b) 4 © 8 (d) 10